Literature DB >> 15953821

Metabolic investigation in psychiatric disorders.

Jeffrey K Yao1, Ravinder D Reddy.   

Abstract

A multiplicity of theories have been proposed over the years that aim to conceptualize the pathophysiology of neuropsychiatric disorders, including impaired neurotransmission, viral infections, genetic mutation, energy metabolism deficiency, excitotoxicity, oxidative stress, and others. It is likely that complex disorders such as schizophrenia, bipolar disorder, and major depression are associated with multiple etiologies and pathogenetic mechanisms. In light of the interwoven biochemistry of human organs, identifying a network of multiple interacting biochemical pathways that account for the constellation of clinical and biological features would advance our understanding of these disorders. One such approach is to evaluate simultaneously the multiple metabolites in order to uncover the dynamic relations in the relevant biochemical systems. These metabolites are a group of low-molecular-weight, redox-active compounds, such as antioxidants, amino acids, catecholamines vitamins, lipids, and nucleotides, which reflect the metabolic processes, including anabolism and catabolism as well as other related cellular processes (e.g., signal transduction, regulation, detoxification, etc.). Such an analytic approach has the potential to yield valuable insights into the likely complex pathophysiological mechanisms that affect multiple metabolic pathways and thereby offer multiple windows of therapeutic opportunities.

Entities:  

Mesh:

Year:  2005        PMID: 15953821     DOI: 10.1385/MN:31:1-3:193

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  21 in total

1.  Characterization of diet-dependent metabolic serotypes: proof of principle in female and male rats.

Authors:  Honglian Shi; Karen E Vigneau-Callahan; Alexander I Shestopalov; Paul E Milbury; Wayne R Matson; Bruce S Kristal
Journal:  J Nutr       Date:  2002-05       Impact factor: 4.798

2.  Exploiting the complementary nature of LC/MALDI/MS/MS and LC/ESI/MS/MS for increased proteome coverage.

Authors:  Wanda M Bodnar; R Kevin Blackburn; Jo M Krise; M Arthur Moseley
Journal:  J Am Soc Mass Spectrom       Date:  2003-09       Impact factor: 3.109

3.  Metabolomics takes its place as latest up-and-coming "omic" science.

Authors:  Charlie Schmidt
Journal:  J Natl Cancer Inst       Date:  2004-05-19       Impact factor: 13.506

4.  Determination of multiple redox-active compounds by high-performance liquid chromatography with coulometric multi-electrode array system.

Authors:  Jeffrey K Yao; Pu Cheng
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-10-15       Impact factor: 3.205

5.  Simultaneous analysis of the majority of low-molecular-weight, redox-active compounds from mitochondria.

Authors:  B S Kristal; K E Vigneau-Callahan; W R Matson
Journal:  Anal Biochem       Date:  1998-10-01       Impact factor: 3.365

6.  Characterization of diet-dependent metabolic serotypes: analytical and biological variability issues in rats.

Authors:  K E Vigneau-Callahan; A I Shestopalov; P E Milbury; W R Matson; B S Kristal
Journal:  J Nutr       Date:  2001-03       Impact factor: 4.798

Review 7.  Free radical pathology and antioxidant defense in schizophrenia: a review.

Authors:  S P Mahadik; S Mukherjee
Journal:  Schizophr Res       Date:  1996-03       Impact factor: 4.939

8.  Purine catabolism: links to mitochondrial respiration and antioxidant defenses?

Authors:  B S Kristal; K E Vigneau-Callahan; A J Moskowitz; W R Matson
Journal:  Arch Biochem Biophys       Date:  1999-10-01       Impact factor: 4.013

9.  Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid.

Authors:  M F Beal; W R Matson; K J Swartz; P H Gamache; E D Bird
Journal:  J Neurochem       Date:  1990-10       Impact factor: 5.372

Review 10.  From membrane phospholipid defects to altered neurotransmission: is arachidonic acid a nexus in the pathophysiology of schizophrenia?

Authors:  P D Skosnik; J K Yao
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2003-12       Impact factor: 4.006

View more
  12 in total

1.  3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia.

Authors:  Ruth Condray; George G Dougherty; Matcheri S Keshavan; Ravinder D Reddy; Gretchen L Haas; Debra M Montrose; Wayne R Matson; Joseph McEvoy; Rima Kaddurah-Daouk; Jeffrey K Yao
Journal:  Int J Neuropsychopharmacol       Date:  2011-01-28       Impact factor: 5.176

2.  Genetic Association Analysis of NOS1 and Methamphetamine-Induced Psychosis Among Japanese.

Authors:  Takenori Okumura; Tomo Okochi; Taro Kishi; Masashi Ikeda; Tsuyoshi Kitajima; Yoko Kinoshita; Kunihiro Kawashima; Tomoko Tsunoka; Yasuhisa Fukuo; Toshiya Inada; Mitsuhiko Yamada; Naohisa Uchimura; Masaomi Iyo; Ichiro Sora; Norio Ozaki; Hiroshi Ujike; Nakao Iwata
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

Review 3.  Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.

Authors:  Jeffrey K Yao; Matcheri S Keshavan
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

4.  The neurometabolic fingerprint of excessive alcohol drinking.

Authors:  Marcus W Meinhardt; Daniel C Sévin; Manuela L Klee; Sandra Dieter; Uwe Sauer; Wolfgang H Sommer
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

5.  No association between polymorphisms of neuronal oxide synthase 1 gene (NOS1) and schizophrenia in a Japanese population.

Authors:  Takenori Okumura; Tomo Okochi; Taro Kishi; Masashi Ikeda; Tsuyoshi Kitajima; Yoshio Yamanouchi; Yoko Kinoshita; Kunihiro Kawashima; Tomoko Tsunoka; Hiroshi Ujike; Toshiya Inada; Norio Ozaki; Nakao Iwata
Journal:  Neuromolecular Med       Date:  2009-06-10       Impact factor: 3.843

6.  Psychological factors in asthma.

Authors:  Ryan J Van Lieshout; Glenda Macqueen
Journal:  Allergy Asthma Clin Immunol       Date:  2008-03-15       Impact factor: 3.406

7.  Altered GABAergic neurotransmission is associated with increased kainate-induced seizure in prostaglandin-endoperoxide synthase-2 deficient mice.

Authors:  Christopher D Toscano; Yumi Ueda; York A Tomita; Stefano Vicini; Francesca Bosetti
Journal:  Brain Res Bull       Date:  2007-11-09       Impact factor: 4.077

8.  Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia.

Authors:  J K Yao; G G Dougherty; R D Reddy; M S Keshavan; D M Montrose; W R Matson; S Rozen; R R Krishnan; J McEvoy; R Kaddurah-Daouk
Journal:  Mol Psychiatry       Date:  2009-04-28       Impact factor: 15.992

9.  Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study.

Authors:  Ashwin A Patkar; Steve Rozen; Paolo Mannelli; Wayne Matson; Chi-Un Pae; K Ranga Krishnan; Rima Kaddurah-Daouk
Journal:  Psychopharmacology (Berl)       Date:  2009-08-01       Impact factor: 4.530

10.  Genetic Association Analysis of NOS3 and Methamphetamine-Induced Psychosis Among Japanese.

Authors:  T Okochi; T Kishi; M Ikeda; T Kitajima; Y Kinoshita; K Kawashima; T Okumura; T Tsunoka; Y Fukuo; T Inada; M Yamada; N Uchimura; M Iyo; I Sora; N Ozaki; H Ujike; N Iwata
Journal:  Curr Neuropharmacol       Date:  2011-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.